Fate Therapeutics Inc
FATE
Market Cap$471.26M
Close$
$8.54
119% upside
Current Fair Value
119% upsideUndervalued by 119% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $471.26 Million |
|---|---|
| Enterprise Value | $87.72 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.92 |
| Beta | 2.85 |
| Outstanding Shares | 113,831,969 |
| Avg 30 Day Volume | 2,997,062 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.48 |
|---|---|
| PEG | -1.61 |
| Price to Sales | - |
| Price to Book Ratio | 1.3 |
| Enterprise Value to Revenue | 13.54 |
| Enterprise Value to EBIT | -0.41 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Fate Therapeutics Inc
CEO: William Rastetter